[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341116-105":59,"doc-detail-341116-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","role-of-fibrinogen-like-protein-1-in-tumor-recurrence-following-hepatectomy","Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy","","Partial hepatectomy serves as a first-line treatment for hepatocellular carcinoma. Within two weeks after surgery, molecular pathways are activated to support liver regeneration, yet residual microtumors can also exploit these programs to reemerge and metastasize. This review discusses fibrinogen-like protein 1 (FGL1) as a therapeutic target, highlighting its differential regulation in regenerative versus malignant cells and its links to proliferative signaling and altered hepatocyte cell-cycle transitions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/role-of-fibrinogen-like-protein-1-in-tumor-recurrence-following-hepatectomy/341116/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/role-of-fibrinogen-like-protein-1-in-tumor-recurrence-following-hepatectomy/341116.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why can tumor recurrence occur after partial hepatectomy?","Question",{"text":112,"@type":113},"Partial hepatectomy activates pathways that drive liver regeneration. Residual microtumors may exploit the same pathways to reappear and metastasize.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does fibrinogen-like protein 1 (FGL1) play in this process?",{"text":117,"@type":113},"FGL1 is elevated in regenerative hepatocytes but downregulated in malignant cells. The review discusses how hepatectomy upregulates FGL1 and how it can promote proliferative and cancer-associated signaling.",{"name":119,"@type":110,"acceptedAnswer":120},"Which signaling pathways are mentioned as downstream of FGL1-related regulation?",{"text":121,"@type":113},"The abstract links FGL1 to proliferative pathways including EGFR/Src/ERK and also discusses involvement of the PI3K/Akt/mTOR pathway and related transcriptional and inflammatory regulators.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341116,1790638183,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Journal of Clinical and Translational Hepatology 2024 vol. 12(4) | 406–415 DOI: 10. 14218/JCTH.2023.00397  \nReview Article  \nRole of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy  \nZahra Shafieizadeh1\\#, Zohreh Shafieizadeh1\\#, Maryam Davoudi1, Reza Afrisham1 and Xiaolei Miao2*  \n1Department of Medical Laboratory Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran; 2School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China  \nReceived: 5 September 2023 | Revised: 29 November 2023 | Accepted: 25 January 2024 | Published online: 25 March 2024  \nAbstract  \nPartial hepatectomy is a first-line treatment for hepatocellular carcinoma. Within 2 weeks following partial hepatectomy, specific molecular pathways are activated to promote liver regeneration. Nevertheless, residual microtumors may also exploit these pathways to reappear and metastasize. Therapeutically targeting molecules that are differentially regulated between normal cells and malignancies, such as fibrinogen-like protein 1 (FGL1), appears to be an effective approach. The potential functions of FGL1 in both regenerative and malignant cells are discussed within the ambit of this review. While FGL1 is normally elevated in regenerative hepatocytes, it is normally downregulated in malignant cells. Hepatectomy does indeed upregulate FGL1 by increasing the release of transcription factors that promote FGL1, including HNF-1α and STAT3, and inflammatory effectors, such as TGF-β and IL6 . This, in turn, stimulates certain proliferative pathways, including EGFR/Src/ERK. Hepatectomy alters the phase transition of highly differentiated hepatocytes from G0 to G1, thereby transforming susceptible cells into cancerous ones. Activation of the PI3K/Akt/mTOR pathway by FGL1 allele loss on chromosome 8, a tumor suppressor area, may also cause hepatocellular carcinoma. Interestingly, FGL1 is specifically expressed in the liver via HNF-1α histone acetylase activity, which triggers lipid metabolic reprogramming in malignancies. FGL1 might also be involved in other carcino-  \nKeywords: Fibrinogen-like protein 1; FGL1; Hepatocellular carcinoma; Liver regeneration; Hepatectomy; Lipogenesis; Recurrence.  \nAbbreviations: ACC, acetyl-CoA carboxylase; ACOX1, acyl-CoA oxidase 1; ACL, ak strain transforming; ACLY, adenosine triphosphate-citrate lyase; BCL, B-cell lymphoma; CCRK, cell cycle-related kinase; CoA, coenzyme A; EGFR, epidermal growth factor receptor; EMT, epithelial-mesenchymal transition; FA, fatty acids; FASN, fatty acid synthase; FGL1, fibrinogen-like protein 1; FOXO1, forkhead box protein O1; GSK3, glycogen-synthase kinase-3; HCC, hepatocellular carcinoma; HIF-1α, hypoxia-inducible factor-1 alpha; HNF-1α, hepatocyte nuclear factor-1 alpha; IL6, interleukin 6; JAK2, the Janus kinase 2; LAG, lymphocyte activation gene; LH, lysyl hydroxylase; MAPK, mitogen-activated protein kinases; MEK, mitogen-activated erk kinase; mTOR, mammalian target of rapamycin; MUFA, monounsaturated fatty acids; PD-L1, programmed cell death ligand 1; PLOD3, the procollagen-lysine,2-oxoglutarate 5-dioxygenase 3; PPAR, peroxisome proliferator-activated receptor; PTM, post translational modification; PH, partial hepatectomy; PI3K, phosphatidylinositol-3-kinase; SREBP1c, sterol regulatory element-binding protein 1c; STAT3, signal transducer and activator of transcription 3; TGF, transforming growth factor; TRM, tissue-resident memory T cells.  \n\\#Contributed equally to this work.  \n*Correspondence to: Xiaolei Miao, School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei 437100, China. ORCID: [https://orcid.org/0000-0001-5513-3247. Tel:](https://orcid.org/0000-0001-5513-3247. Tel:) +86-13720365703,  \nE-mail: [345701500@qq.com](345701500@qq.com)  \ngenesis processes such as hypoxia, epithelial-mesenchymal transition, immunosuppression, and sorafenib-medi","cbCaijDZX4mxnEsm","https://ap.wps.com/l/cbCaijDZX4mxnEsm","pdf",2885879,"English","# Introduction\n## Liver regeneration and tumor recurrence after partial hepatectomy\n## FGL1 as a hepatokine and regulatory target\n# Review Article Abstract\n## FGL1 functions in regenerative and malignant contexts","[{\"question\":\"Why can tumor recurrence occur after partial hepatectomy?\",\"answer\":\"Partial hepatectomy activates pathways that drive liver regeneration. Residual microtumors may exploit the same pathways to reappear and metastasize.\"},{\"question\":\"What role does fibrinogen-like protein 1 (FGL1) play in this process?\",\"answer\":\"FGL1 is elevated in regenerative hepatocytes but downregulated in malignant cells. The review discusses how hepatectomy upregulates FGL1 and how it can promote proliferative and cancer-associated signaling.\"},{\"question\":\"Which signaling pathways are mentioned as downstream of FGL1-related regulation?\",\"answer\":\"The abstract links FGL1 to proliferative pathways including EGFR/Src/ERK and also discusses involvement of the PI3K/Akt/mTOR pathway and related transcriptional and inflammatory regulators.\"}]","Role of Fibrinogen-like Protein 1 in Tumor Recurrence Following Hepatectomy | PDF",1790040395,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42f8481880cecefca78b3ea2253dd8b8.webp",983,1324,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a9c516512e9541f99e165704c894630.webp",982,1323,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f055a096a857846c4a0e123181c14916.webp",981,1321,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9e28117581190724d9ea10fdb3fe444.webp",980,1320]